ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
121.077,50
0,26%
S&P 500
6.037,59
1,06%
US Dollar vs BRL
6,1835
-8,29%
Bitcoin
94.672,97
-1,06%
Brent Oil
73,045
0,21%
As Melhores Corretoras Online
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NYSE
  6. SQZ Biotechnologies Company (SQZ)

  7. SQZ Biotechnologies Company (SQZ) Notícias

SQZ

SQZ Biotechnologies (SQZ)

SQZ Biotechnologies Company
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NYSE:SQZ
DataHoraFonteTítuloCódigoCompanhia
06/05/202407:25GlobeNewswire Inc.Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd WiderNYSE:SQZSQZ Biotechnologies Company
23/01/202418:31Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNYSE:SQZSQZ Biotechnologies Company
22/12/202319:18Edgar (US Regulatory)Form 8-K - Current reportNYSE:SQZSQZ Biotechnologies Company
08/11/202318:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:SQZSQZ Biotechnologies Company
15/06/202317:47Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:SQZSQZ Biotechnologies Company
15/06/202317:38Edgar (US Regulatory)Current Report Filing (8-k)NYSE:SQZSQZ Biotechnologies Company
15/06/202317:30Business WireSQZ Biotechnologies to Consolidate Shares with 1-for-10 Reverse Stock SplitNYSE:SQZSQZ Biotechnologies Company
10/05/202317:45Business WireSQZ Biotechnologies Reports First Quarter 2023 Financial Results and Recent Portfolio UpdatesNYSE:SQZSQZ Biotechnologies Company
10/05/202317:35Edgar (US Regulatory)Quarterly Report (10-q)NYSE:SQZSQZ Biotechnologies Company
05/05/202317:32Edgar (US Regulatory)Annual Report to Security Holders (ars)NYSE:SQZSQZ Biotechnologies Company
26/04/202317:32Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NYSE:SQZSQZ Biotechnologies Company
26/04/202317:31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NYSE:SQZSQZ Biotechnologies Company
10/04/202317:32Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NYSE:SQZSQZ Biotechnologies Company
22/03/202317:50Business WireSQZ Biotechnologies Announces Confirmed Complete Response in HPV16+ Solid Tumor Patient in the Lowest-Dose Cohort of the SQZ-AAC-HPV-101 Clinical TrialNYSE:SQZSQZ Biotechnologies Company
22/03/202317:45Business WireSQZ Biotechnologies Reports Full Year 2022 Financial Results and Recent Portfolio UpdatesNYSE:SQZSQZ Biotechnologies Company
14/02/202316:25Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:SQZSQZ Biotechnologies Company
18/01/202318:30Business WireSQZ Biotechnologies Receives Notice Regarding Continued Listing Standards From the New York Stock ExchangeNYSE:SQZSQZ Biotechnologies Company
06/12/202213:55TipRanksSQZ Biotechnologies (SQZ) Gets a Hold from H.C. WainwrightNYSE:SQZSQZ Biotechnologies Company
06/12/202210:55TipRanksSQZ Biotechnologies (SQZ) Receives a Buy from Brookline Capital MarketsNYSE:SQZSQZ Biotechnologies Company
06/12/202208:45Business WireSQZ Biotechnologies Receives FDA Fast Track Designation for its eAPC Therapeutic Candidate for Treatment of HPV16+ Tumors and Presents Clinical Data for Multiple Programs at the European Society for Medical Oncology Immuno-Oncology CongressNYSE:SQZSQZ Biotechnologies Company
02/12/202208:15TipRanksSQZ Biotechnologies (SQZ) was downgraded to a Hold Rating at H.C. WainwrightNYSE:SQZSQZ Biotechnologies Company
01/12/202209:55TipRanksChardan Capital Sticks to Their Buy Rating for SQZ Biotechnologies (SQZ)NYSE:SQZSQZ Biotechnologies Company
30/11/202218:30Business WireSQZ Biotechnologies Announces Strategic Prioritization of SQZ® Enhanced Antigen Presenting Cells Program; Armon Sharei to Step Down as Chief Executive OfficerNYSE:SQZSQZ Biotechnologies Company
10/11/202211:00Business WireSQZ Biotechnologies Presents Cell Squeeze® Manufacturing Platform, Linked Antigen mRNA Preclinical Research, and COMMANDER-001 Phase 1/2 Clinical Trial in Progress Poster at Society for Immunotherapy of Cancer Annual MeetingNYSE:SQZSQZ Biotechnologies Company
10/11/202208:17TipRanksSQZ Biotechnologies (SQZ) Receives a Buy from H.C. WainwrightNYSE:SQZSQZ Biotechnologies Company
09/11/202221:55TipRanksBrookline Capital Markets Reaffirms Their Buy Rating on SQZ Biotechnologies (SQZ)NYSE:SQZSQZ Biotechnologies Company
09/11/202218:30Business WireSQZ Biotechnologies Reports Third Quarter 2022 Financial Results and Recent Portfolio UpdatesNYSE:SQZSQZ Biotechnologies Company
03/10/202207:45Business WireSQZ Biotechnologies Publishes Preclinical Research Demonstrating SQZ® AAC Platform’s Potential as an Effective Red Blood Cell-Derived ImmunotherapyNYSE:SQZSQZ Biotechnologies Company
12/09/202210:15TipRanksBrookline Capital Markets Keeps Their Buy Rating on SQZ Biotechnologies (SQZ)NYSE:SQZSQZ Biotechnologies Company
12/09/202207:00Business WireSQZ Biotechnologies Presents Preclinical SQZ® TIL Data Supporting Potential Ability of mRNA-Driven IL-2 and IL-12 Expression to Eliminate Need for Toxic Preconditioning and Systemic IL-2 Administration for Certain T Cell TherapiesNYSE:SQZSQZ Biotechnologies Company
 Apresentando as notícias mais relevantes sobre:NYSE:SQZ

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
BRAV3
Brava Energia ON
BOV
AERI3
Aeris Industria E Comerc... ON
BOV
BHIA3
Grupo Casas Bahia ON
BOV
FICT3
Fictor Alimentos ON
BOV
GFSA3
GAFISA ON
BOV
COGN3
COGNA ON
BOV
CSAN3
COSAN ON
BOV
AZEV4
AZEVEDO PN
BOV
RAIZ4
Raizen S.A PN
BOV
RCSL4
RECRUSUL PN
BOV
MGLU3
MAGAZINE LUIZA ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados